Meningitis B Vaccine

Article published on 18th May 2008

Meningitis is often cited as one of the prime concerns parents have for their children's health - particularly in babies and young children. Its symptoms include a sudden fever, headache, rashes and stiffness in the neck can advance very quickly unless medical treatments if sought out. The infection, which can kill in a matter of hours from when the first symptoms manifest, causes an inflammation of the lining around the brain and can kill one in ten of sufferers.

But now, thanks to a team of British scientists based at Novartis Vaccines and Diagnostics based in Surrey, a vaccine against Meningitis B (the most common strain of the disease) may well be on the health market within three years. Although tests are still underway, a European medical conference has been told that preliminary trials of the vaccine have been successful and now more widespread tests being carried out.

The meningitis C vaccine has already brought about a dramatic reduction in cases of that strain but until the meningitis B vaccine has been perfected there is no guaranteed form of prevention.

As babies and infants are at greatest risk of the disease a vaccine would benefit thousands of families worldwide. However, even within meningitis B there are numerous strains of the disease. As yet the vaccine was found to have very good results against the three major types of meningitis B.

Looking for more information?

Search Archive of Articles

Enter your search term here:

Or choose a category or archive date to view by:

Feel free to share this page or follow us on these social site